A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis
{{output}}
Background: Teriflunomide is a once-daily oral immunomodulator for the treatment of relapsing-remitting MS. Objective: To evaluate the safety a... ...
